Lifecare ASA: Livestream strategic update
Posted: 16/05/2025

Bergen, Norway, 16 May 2025 – Lifecare ASA (LIFE), a medtech company developing next generation continuous glucose monitoring (CGM) solutions for diabetes management, announces that CEO Joacim Holter will participate at a livestream strategic update event at DNB Carnegie Stockholm Monday 19 May 2025, 12:00 CEST.
To register for livestream followed by a Q&A session, please click here.
Key highlights from the presentation:
Diabetes is a trillion-dollar global healthcare challenge
- CGMs the fastest growing diabetes tech segment, representing a USD 30 billion market opportunity
- Within CGMs, implantable solutions represent a USD 5 billion potential market
Strong value drivers in place 2025-2028
- Set to capitalize on “second mover” advantage, leveraging first mover regulatory approvals in the US
- Capital efficient path to commercialization with partner-led go-to-market strategy and minimal additional R&D
- Near-term value inflection points including veterinary market launch late 2025, CE mark in 2026, and European human market launch in 2027
Significant value creation potential
- Peak revenue potential of USD 1 billion + on realistic market assumptions
- Revenue sustainable at high levels long-term assuming conservative market share in a growing market
- EBITDA margin of 35%+
The presentation is available at: https://lifecare.no/investor/